Actual Medicinal Product (AMP) Elstabya 80mg tablets (Amarox Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Medicines suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
- Notes
-
No special precautions for storage.
- Provenance
-
This compatibility recommendation is derived from Adenuric 80mg tablets (A. Menarini Farmaceutica Internazionale SRL).
- Generic
- Febuxostat
- Formulation
- Febuxostat 80mg tablets
-
Febuxostat
-
Febuxostat 80mg tablets
-
Elstabya 80mg tablets (Amarox Ltd)
-
-